Biohaven

Biohaven Stock Surges 37%: FDA Gives Vyglxia a Second Chance After Last Year's Rejection

2026-10-22

Biohaven (NYSE: BHVN) stock surged as much as 39% in premarket trading on Thursday, October 22, 2026, after the U.S. Food and Drug Administration accepted the company's resubmitted application for...